For example, anti-topoisomerase type I antibodies (ATA) are usually associated with diffuse cutaneous SSc (dcSSc) and the presence, severity, and progression of interstitial lung disease, whereas anticentromere antibodies (ACA) are associated with limited cutaneous SSc (lcSSc) and pulmonary arterial hypertension (1). Here, ATM is linked to interstitial lung disease.